Bioethical challenges with HIV treatment as prevention

Jeremy Sugarman

doi:10.1093/cid/ciu246

Bioethical challenges with HIV treatment as prevention

Clin Infect Dis. 2014 Jul;59 Suppl 1(Suppl 1):S32-4. doi: 10.1093/cid/ciu246.

Author

Jeremy Sugarman¹

Affiliation

¹ Berman Institute of Bioethics, Johns Hopkins University School of Medicine Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Abstract

To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.

Keywords: HIV prevention; HIV treatment; ethics; policy.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Anti-Retroviral Agents / therapeutic use*
Bioethical Issues
HIV Infections / drug therapy*
Humans

Substances

Anti-Retroviral Agents

Abstract

Publication types

MeSH terms

Substances

Grants and funding